Premium
Proven Aspergillus flavus pulmonary aspergillosis in a COVID‐19 patient: A case report and review of the literature
Author(s) -
Salehi Mohammadreza,
Khajavirad Nasim,
Seifi Arash,
Salahshour Faeze,
Jahanbin Behnaz,
Kazemizadeh Hossein,
Hashemi Sayed Jamal,
Dehghan Manshadi Seyed Ali,
Kord Mohammad,
Verweij Paul E.,
Khodavaisy Sadegh
Publication year - 2021
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.13255
Subject(s) - pulmonary aspergillosis , aspergillus flavus , aspergillosis , covid-19 , aspergillus , medicine , intensive care medicine , pathology , immunology , microbiology and biotechnology , biology , infectious disease (medical specialty) , disease
Severe COVID‐19 patients complicated with aspergillosis are increasingly reported. We present a histopathological proven case of fatal COVID‐19–associated pulmonary aspergillosis (CAPA), due to Aspergillus flavus . This report and existing published literature indicate diagnostic challenges and poor outcomes of CAPA in ICU patients.